Biosimilars & Biologics Reports

Showing 1–12 of 22 results

The recent FDA draft-guidance serves as yet another clear indication that biosimilars are becoming a major factor in the healthcare industry. As your organization develops and executes your biosimilar strategy, understanding various stakeholders’ needs, biases, and perceptions will be a strategic advantage.

Call us at +1 (919) 301-0106 for more information on our Biosimilars & Biologics Reports, or email us at sales@isrreports.com.

  • Commercial Bioprocessing Market Outlook

    $4,710.00$9,420.00
  • Bioprocessing Market Outlook (3rd Ed.)

    $4,460.00$8,920.00
  • Bioprocessing Market Outlook (2nd Ed.)

    $4,460.00$8,920.00
  • Biosimilars Manufacturing Outsourcing Models (4th Ed.)

    $1,460.00$2,920.00
  • Development vs Commercial Outsourced Manufacturing Practices: Biologics

    $4,960.00$9,920.00
  • Biologic API Contract Manufacturer Quality Benchmarking (2nd edition)

    $5,400.00$10,800.00
  • Bioprocessing Services and Technologies Market Trends and Outsourcing Dynamics

    $4,960.00$9,920.00
  • Biosimilars in the US Oncology Market (2nd Edition)

    $960.00$1,920.00
  • Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (3rd Edition)

    $900.00$1,800.00
  • Bioprocessing Market Trends and Outsourcing Dynamics: 2016-2021

    $4,960.00$9,920.00
  • Biologic API Contract Manufacturer Quality Benchmarking (2016)

    $4,960.00$9,920.00
  • Biosimilars Manufacturing: Key Considerations and Expected Outsourcing Practices (2015)

    $750.00$1,500.00